MADISON INTERNATIONAL REALTY ANNOUNCES FINAL CLOSE OF FUND VIII WITH $1.7 BILLION OF EQUITY COMMITMENTS

NEW YORK, Sept. 5, 2023Madison International Realty, a leading liquidity provider to real estate investors worldwide, announced the final closing of Madison International Real Estate Liquidity Fund VIII, its latest commingled investment vehicle, with $1.7 billion of equity commitments, including side cars, co-investment vehicles and general partner commitments.

“In the midst of a volatile market and an extremely challenging fundraising climate, investors have continued to demonstrate confidence in Madison’s differentiated strategy,” said Ronald M. Dickerman, Madison International Realty Founder and President. “We are gratified with the robust support we have received from both returning and new investors for Madison VIII’s capital raise.  Madison’s direct secondary investment strategy is targeted to be counter-cyclical, allowing us to leverage opportunities in rapidly changing economic conditions.

“Given our position as a liquidity provider, we have been able to make well-timed investments and increase our allocations to tech enabled, growth oriented real estate asset classes,” Dickerman said.

Madison International Realty focuses on the acquisition of ownership stakes in prime properties and portfolios in demographically compelling geographies of the US, UK, and Europe. Madison VIII is invested or specified in several diversified investments in the multi-family, industrial, cold storage, single family rental, life science, and data center sectors across the US, UK, and Europe.

Madison VIII investors include endowments, foundations, public and private pension funds, sovereign wealth funds, family offices, insurance companies and high net worth individuals in the US, Europe, Asia, the Middle East, and Australia.

About Madison International Realty
Madison International Realty (www.madisonint.com) is a leading liquidity provider to real estate investors worldwide. Madison provides equity capital for real estate owners and investors seeking to monetize embedded equity, replace capital partners seeking an exit or to recapitalize balance sheets. The firm provides equity for recapitalizations, partner buyouts and capital infusions; and acquires joint venture, limited partner and co-investment interests as principals. In addition, Madison provides strategic growth capital to established, middle-market real estate operating platforms, seeking to accelerate their growth and investment programs. Madison has offices in New York, Los Angeles, London, Luxembourg, Amsterdam, and Frankfurt, where the firm operates under the name of Madison International Realty GmbH.

SOURCE Madison International Realty

Sports stars join APEX’s athlete driven fund to invest across sports, media and entertainment

LISBON, Portugal, Sept. 5, 2023APEX, an athlete-driven investment company, today announced the launch of its new €50 million Elite Performance Fund. This investment vehicle is poised to reshape the landscape of sports, media, and entertainment by channeling the expertise and vision of world-renowned athletes such as Formula 1 sensations Lando Norris and Carlos Sainz and FIFA World Cup and UEFA Champions League winner Raphaël Varane

The fund’s core philosophy revolves around fostering innovative solutions that redefine the boundaries of the sports, media, and entertainment industries. Investors gain privileged access to a diverse portfolio meticulously managed by APEX’s team of experts known for their credibility and ability to find the right opportunities in the market.

Also joining the list of star investors are, among others, F1’s Valtteri Bottas, international footballers Christian Eriksen and Daley Blind and surfer Kanoa Igarashi.

APEX CEO António Caçorino said, “This fund fuses the drive, dedication, and performance mindset of athletes with forward-looking investment strategies. Unlike typical investors, our roots, experience, and insights come directly from the sports world. Athletes aren’t just our capital sources; they’re our partners.”

Lando Norris, McLaren Formula 1 driver: “As an athlete, I’m always focused on performing at my best, so it’s going to be exciting to apply this perspective when I’m working alongside APEX to drive innovation in the sports, media and entertainment space.”

Carlos Sainz, Ferrari F1 driver: “Being deeply involved in sports has given me a unique perspective on its landscape. With APEX’s guidance, I’m tapping into that insight to discover exciting investment opportunities. It’s not just about capital for me; it’s about strategically positioning myself as a genuine contributor in the sports investment world.”

Raphaël Varane, Manchester United and France international: “I have been investing in startups for some time now. Gaining access to the right opportunities is paramount. By joining APEX, I will not only be able to access the right opportunities, on top of that I can share my investment experiences with other athletes and learn from theirs. A powerful and exciting combination.”

Kanoa Igarashi, WSL Surfer, Olympic medalist: “By partnering with APEX, I can invest and collaborate with companies that have the potential to shape the future of sports. I believe that through my experiences as a professional athlete, I can add unique insights as an investor.”

The Portuguese investment company has already invested in other elite sports ventures such as TMRW SPORTS’ Tiger Woods and Rory McIlroy (https://tmrwsportsgroup.com/tmrw-sports-adds-all-star-investors).

SOURCE APEX


IndoSpace Logistics Parks IV fundraising reaches $393M with second close led by QIA and Grosvenor

SINGAPORE and MUMBAI, India, Sept. 5, 2023 — IndoSpace, the largest investor, developer, and operator of grade A industrial and logistics real estate in India, is pleased to announce the successful completion of its second round of fundraising for IndoSpace Logistics Parks IV (“ILP IV”), securing an additional USD 150 million in investment. The round was led by the Qatar Investment Authority (“QIA”), and Grosvenor’s Diversified Property Investments business.

Following the initial close of USD 243 million, this second round of funding increases the fund size to USD 393 million and demonstrates the continued confidence and support from leading global investors in IndoSpace’s advanced approach to industrial real estate development in India.

QIA and Grosvenor’s participation in this round reflects the attractive opportunity to develop modern grade A industrial and logistic parks in the world’s fastest growing large economy. The funds raised in this round will continue to advance IndoSpace’s mission of developing state-of-the-art industrial and logistics parks across the top 8 markets in India.

With a strong focus on sustainability and modern design, IndoSpace provides world-class infrastructure and tailored solutions to meet the evolving needs of businesses operating in the e-commerce, manufacturing, retail, and logistics sectors.

IndoSpace has a proven track record of leveraging its deep understanding of market dynamics and strong industry relationships to deliver returns to investors while also driving economic growth and job creation in India.

ILP IV will add an additional 25-30 million square feet to the IndoSpace portfolio, furthering IndoSpace’s leading position in the Indian market. ILP IV will focus on India’s largest logistics real estate markets: Ahmedabad, Bangalore, Chennai, Delhi, Hyderabad, Kolkata, Mumbai, and Pune. The establishment of ILP IV follows on from the first three development funds, which have a combined total of 58 million square feet of modern logistics real estate in India completed and under development.

About Qatar Investment Authority

Qatar Investment Authority (“QIA”) is the sovereign wealth fund of the State of Qatar. QIA was founded in 2005 to invest and manage the state reserve funds. QIA is among the largest and most active sovereign wealth funds globally. QIA invests across a wide range of asset classes and regions as well as in partnership with leading institutions around the world to build a global and diversified investment portfolio with a long-term perspective that can deliver sustainable returns and contribute to the prosperity of the State of Qatar.

About Grosvenor Diversified Property Investments

Grosvenor Diversified Property Investments backs local partners globally, who share Grosvenor’s core values, have specialist expertise and a demonstrable investment track record. The team sits within the wider Grosvenor business, an international organisation whose activities span urban property, food and agtech, rural estate management and support for philanthropic initiatives. By investing Grosvenor’s own capital alongside local partners who have a clear understanding of the changing demands of real estate in their markets, the business aims to generate strong commercial results, while advancing Grosvenor’s social and environmental ambitions. Since its first partnership in 2012, the team has successfully backed aligned, specialist, local management teams across five continents and in a broad range of sectors including industrial/ logistics, student accommodation, life sciences, healthcare, housing, and offices. Find out more here.

About IndoSpace

IndoSpace (www.indospace.in) is the largest investor, developer, and operator of grade A industrial and logistics real estate in India. IndoSpace has the largest national network of 51 logistics parks with 58 million square feet delivered/under development across 11 cities. With India’s largest and most experienced industrial real estate team, IndoSpace continues to lead the development of key logistics infrastructure for India’s economic growth. For more information, visit www.indospace.in and follow us on LinkedIn, Twitter, and Facebook.

Photo: https://mma.prnewswire.com/media/2201490/IndoSpace_Park.jpg

SOURCE IndoSpace


Six companies enter BioInnovation Institute’s Venture House program receiving additional financial support

COPENHAGEN, Denmark, Sept. 5, 2023 — BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that six companies are to receive additional financial support through its Venture House program, created to further support former Venture Lab companies through their next phase of growth.

The Venture House program provides exclusive follow-on funding in the form of a founder-friendly convertible loan of EUR 1.3M to selected companies that have already participated in the 12-month Venture Lab program created to support business acceleration, scientific and team development. As part of the Venture House program, companies will also take advantage of BII’s extensive network to help establish a strong board, chairman and key scientific advisors. This is the third cohort of companies to be accepted into the Venture House program since its launch in August 2022.

To support product innovation and ecosystem growth, the program consists of four executive sprints, each focused on a key development area to help mature the project and ultimately attract further funding. The first sprint focuses on helping companies develop an operational plan, while the following sprints provide training and support in fundraising, partnership, and leadership.

Bobby Soni, Chief Business Officer at BioInnovation Institute, said: “These six companies have shown promise during their time in the Venture Lab program and collectively align with BII’s focus on providing solutions to benefit people and society. On behalf of the team at BII, we look forward to continuing to work alongside these innovative companies as they mature and attract funding.”

All six companies have partaken in BII’s Venture Lab program that supports business acceleration, scientific development and team development in which each company received a risk-free convertible loan of EUR 500,000 plus access to labs and offices at the BII’s entrepreneurial ecosystem in the center of Copenhagen. Thus, after entering the Venture House program they have received in total EUR 1.8M. The new companies the BII has accepted into the Venture House program are:

  • TriptoBIO is developing a high-value plant compound production platform focused on triptolide to liberate the world from rat poison.
  • Agrobiomics develops transformative natural solutions, with a vision of securing sustainable food supply, that make agriculture resilient to climate change. The Company’s solutions are affordable and highly potent, thereby enabling growers globally to increase yields of crops affected by abiotic stress such as salinity and drought.
  • MATR Foods is producing delicious new plant food from the side streams of the current food industry.
  • HHC Medical is building a platform technology for non-viral delivery of genetic therapies. The approach will enable genetic therapies to be delivered very specifically to a target volume anywhere in the body.
  • Solid Therapeutics is developing novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
  • FimmCyte is dedicated to developing tailored women’s health therapeutics. FimmCyte’s lead program, FMC2, is a first-in-class disease-modifying treatment for endometriosis. FimmCyte is jointly supported by BII and Ferring Pharmaceuticals through a strategic collaboration.

Since its inception in 2018, BII has supported 87 start-ups and projects with EUR 85 million alongside the venture capital, industry and business expertise it provides to help them accelerate to the next level. In total, BII’s start-ups have raised over EUR 424 million in external funding from both local and international investors. Recent company successes include Embark Laboratories, Adcendo, Stipe Therapeutics, Twelve Bio, Octarine Bio, and Cirqle Biomedical.

Read more about the Venture House program here.

About the BioInnovation Institute Foundation:

At BioInnovation Institute (BII), we accelerate world-class life science start-up innovation for the benefit of people and society. As a non-profit institute, BII operates the company creation programs, Bio Studio, Venture Lab and Venture House, to support life science start-ups with knowledge, network, infrastructure and funding of up to 3M EUR per projects and 1,8 M EUR per start-up. With our expertise, network, funding, and infrastructure, we empower startups to succeed and believe in the transformative power of life science innovation. Read more on www.bioinnovationinstitute.com 

SOURCE BioInnovation Institute


AlixLabs secures SEK 40 million investment to advance energy-efficient semiconductor innovation

LUND, Sweden, Sept. 5, 2023Swedish semiconductor trailblazer, AlixLabs, has successfully secured SEK 40 million in funding to accelerate their pioneering work. Specializing in semiconductor advancements, AlixLabs has developed a revolutionary Atomic Layer Etching (ALE) Pitch Splitting technology (APS), which has attracted substantial investment from notable backers including Navigare Ventures, Industrifonden, and FORWARD.one. This marks a significant step towards transforming semiconductor manufacturing by making it more energy-efficient and cost-effective.

The semiconductor industry has long faced challenges related to escalating expenses, particularly due to the high costs of Extreme Ultraviolet Lithography (EUV) equipment and has an escalating need for energy-efficient alternatives and more sustainable practices. AlixLabs is disrupting the semiconductor landscape with their innovative approach to manufacturing. Through their ALE Pitch Splitting technology (APS), they enable the precise division of nanostructures while significantly reducing energy consumption and emissions. This breakthrough has now caught the attention of investors, as it addresses the rising costs associated with current manufacturing techniques.

Jonas Sundqvist, CEO of AlixLabs, stated: “The investment plays a pivotal role in propelling our company towards scalable success. The infusion of capital not only validates our vision but also empowers us to bring our groundbreaking technology to the forefront of semiconductor manufacturing. This investment marks a significant milestone as we work towards our goal: to have our meticulously developed process adopted by circuit manufacturers in their most advanced production by 2025. With this support, we are forging a path to transform the semiconductor landscape and usher in a new era of efficiency and innovation.”

AlixLabs’ innovation arrives at an opportune moment, with the European Union’s ambitious semiconductor initiative, the EU Chips Act, allocating substantial resources for semiconductor companies. With over 43 billion euros earmarked for the next five years, this initiative complements AlixLabs’ mission to drive technological progress and sustainable manufacturing.

Alex Basu, Investment Manager at Navigare Ventures, said: “AlixLabs has taken considerable steps in establishing itself as an emerging equipment manufacturer, contributing to the fast growing European semiconductor industry. We look forward to a continued partnership as they bring their technology to production in the coming years.”

Tobias Elmquist, Senior Investment Director, commented: “At Industrifonden, we’re committed to science-backed, scalable investments that have the power to drive meaningful change in society. AlixLabs is redefining semiconductor manufacturing and we’re proud to support them on their journey towards a more efficient and sustainable industry.”

Arjan Göbel, partner at FORWARD.one:”The technology that AlixLabs has developed solves real problems for its semiconductor customers and adds a lot of value for them by reducing the complexity of making chips and making the process much cheaper while reducing the environmental impact of the process significantly. Doing this with a very skilled and ambitious team, makes it a great investment for FORWARD.one.”

Contact:

Jonas Sundqvist, CEO of AlixLabs, phone +46 767 63 94 67, email [email protected]

The following files are available for download:

SOURCE AlixLabs AB

ViAqua Therapeutics Announces $8.25M Investment Led by S2G Ventures to Scale RNA-Based Solutions in Aquaculture

Funding will enable ViAqua to bring its first product to market, invest in R&D for future products, and prove the platform’s ability to deliver RNA-based solutions at scale.

HAIFA, Israel, Sept. 5, 2023 ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture, announced it has completed a US$8.25M round led by S2G Ventures with participation from Rabo Ventures, The Trendlines Group Ltd., Agriline Limited, Nutreco, I-Lab Angels and Circle Investments LLC.

Aquaculture is essential for improving food security, providing a healthy and sustainable food source, and protecting wild fish stocks in the face of growing demand for marine protein. But disease management is currently the biggest issue facing the aquaculture industry, resulting in more than $8.5 billion in economic impact for the shrimp industry alone, according to an analysis from Kontali.

To address this problem, ViAqua has developed a biotechnology-based oral delivery platform for the targeted administration of RNA-based solutions to improve disease resistance in aquaculture.

“Oral delivery is the holy grail of aquaculture health development due to both the impossibility of vaccinating individual shrimp and its ability to substantially bring down the operational costs of disease management while improving outcomes,” said Shai Ufaz, chief executive officer of ViAqua. “We are excited to bring this technology to market to address the need for affordable disease solutions in aquaculture.”

Shrimp, one of the most widely consumed seafood products globally, in particular, are very susceptible to disease due to their lack of adaptive immune systems, and there are currently no products available that address shrimp disease today. The company’s first product is a feed supplement to enhance resistance to viral infections in shrimp, with the initial application targeting White Spot Virus (WSSV), which causes an annual loss of around $3 billion and a 15 percent reduction in global shrimp production. This solution will provide much-needed production stability for farmers while also creating the opportunity to increase production per farm without increasing disease risk.

“Aquaculture is critical for the sustainable supply of marine protein,” said Kate Danaher, managing director of S2G Ventures’ Ocean and Seafood fund. “ViAqua’s platform technology will enable the company to move beyond WSSV to address numerous other diseases in aquaculture while similar technologies are still years away from reaching the market.”

ViAqua produces its capsule products using commercial, industrial processes and is scaling production to take its first product to market. With plans to begin production in India at the beginning of 2024, the company has established a commercial partnership through a joint development and marketing agreement with Skretting, a Nutreco company, to bring the product to the market. While ViAqua is currently focused on shrimp production, the delivery technology has numerous applications in aquaculture and beyond, which the company is excited to explore.

“We are truly excited by the potential of ViAqua’s technology because of the value it unlocks for the planet and the farmers. Diseases cause mortality rates of up to 50%, which result in 25-30% of shrimp farms failing annually. This is tremendously unproductive and hurts a lot of livelihoods,” explained Shishir Sinha, investment director at Rabo Ventures. “Our bank’s aquaculture specialists Gorjan Nikolik and Novel Sharma were impressed by the game-changing impact potential of having a solution for an issue that has plagued the sector for decades and can make a meaningful difference in the lives of the smallholder farmers, who represent 80% of supply.”

About ViAqua Therapeutics

ViAqua was established to address the growing need for effective, specific, and affordable health management of diseases in aquaculture. One of the major challenges facing the shift to sustainable aquaculture practice is the prevention and treatment of disease. ViAqua is developing a biotechnology-based, oral delivery platform for administration of nucleic acid-based solutions for promoting health in marine species.

About S2G Ventures:

S2G Ventures, the direct investment team of Builders Vision, partners with entrepreneurs who are working on solutions to some of the world’s greatest challenges across the food, agriculture, oceans, and clean energy markets. We provide capital, mentorship, and value-added resources to companies pursuing innovative market-based solutions that generate positive social, environmental, and financial returns. We provide our partners with flexible capital solutions that can range from seed and venture funding through growth equity to debt and infrastructure financing. For more information about S2G, visit s2gventures.com or connect with us on LinkedIn.

About Rabo Ventures:

Rabo Ventures, part of Rabobank, partners with early stage companies across the value chain to support their growth ambitions and enable the vital transitions needed in global Food & Agriculture. We invest behind stellar management teams building solutions for real problems with a focus on driving innovation and sustainability. With a local presence in 25 countries and over 100 dedicated sector specialists and researchers, Rabobank is the global leader in Food & Agriculture banking. As part of Rabobank’s captive investment franchise, Rabo Investments, we leverage the banks platform, knowledge and network to help sustain and grow your business while accelerating transitions that matter.

Media Contact:
Ally Dunne
Ally.Dunne@zenogroup.com

SOURCE ViAqua Therapeutics

Facets.cloud Raises $4 Million in Seed Funding to Revolutionize DevOps

The self-serve infrastructure management platform is helping companies adopt the future of DevOps.

LEWES, Del., Sept. 4, 2023Facets.cloud, a self-serve infrastructure management platform, has raised $4 million in a seed funding round led by 3one4 Capital. The platform helps improve developer productivity by streamlining and productizing cloud deployment workflows.

Facets was co-founded in 2021 by Anshul Sao, Pravanjan Choudhury, and Rohit Raveendran – all three are alumni of IIT-KGP.

Modern DevOps practices today entail Ops teams stitching together 32 categories of toolchains to manage environment provisioning, releases, observability, and other aspects of the cloud delivery process. This approach requires a mind-numbing amount of effort to maintain, update and keep in sync with the ever-changing requirements. This poses a distraction for organizations from their core business offerings.

Cloud delivery of products is an incidental complexity that businesses have to deal with. Anything that’s not core to your business and taking away your Developers’ time is noise and needs to be productized,” says Pravanjan Choudhury, founder and CEO at Facets.

Facets streamlines all the cloud deployment processes into an Internal Developer Platform, making it easy for Developers to self-serve their infrastructure needs. This new way of attempting cloud delivery is called Platform Engineering and Facets is designed to help companies adopt this practice.

Commenting on the funding, Choudhury said: “The infusion of $4 million is a testament to the immense potential of Facets and the platform engineering philosophy we embody. We are grateful for the trust shown by 3one4 Capital and other investors.

Before Facets, Choudhury worked as the CTO of Capillary Technologies for close to 10 years. Anshul Sao was previously the Chief Architect at Capillary Technologies and also worked at Yahoo, while Rohit Raveendran was the Principal Architect at Capillary. Facets is used by companies like MPL, Treebo, Capillary Technologies, Purplle, among others.

Facets is a game-changer for complex DevOps setups. By automating last-mile cloud delivery as a product, it empowers businesses with self-service infrastructure management, enabling enhanced efficiency and positioning them as industry leaders. Their approach to platform engineering has the potential to transform the landscape. We believe in the immense potential of Facets to redefine how organizations manage their DevOps and are proud partners in their growth journey,” stated Anurag Ramdasan, the lead partner from 3one4 Capital.

Facets aims to use this capital to expand in the US market, promote and advance the platform engineering philosophy and enhance its product offerings.

Other investors who participated in the round were 100x Entrepreneurs (now Neon), and prominent angels like Abhinav Asthana, Pallav Nadhani, Aneesh Reddy, Krishna Mehra, and Sreedhar Pedinneni, among others.

About Facets.cloud:

Facets is a ready-to-use Internal Developer Platform that enables self-serve deployment and standardizes DevOps workflows. Built on the philosophy of platform engineering, Facets helps Devs self-serve their infra needs. Visit www.facets.cloud

Photo: https://mma.prnewswire.com/media/2200849/Facets_cloud_Founders.jpg
Logo: https://mma.prnewswire.com/media/2200848/Facets_cloud_Logo.jpg

SOURCE Facets.Cloud India Private Limited


ReOrbit Completes Oversubscribed $7.4M Seed Funding Round: Enabling Real-Time Dataflow in Space

HELSINKI, Sept. 4, 2023 ReOrbit, a Helsinki-based leading provider of software-enabled satellites, has completed an oversubscribed Seed funding round for US $7.4M, led by Inventure VC, along with participation from 10x Founders, existing investor Icebreaker.vc, Expansion, and Yes VC.

ReOrbit enables real-time dataflow in space and provides Earth Observation and SatCom operators with flight software, satellite platforms, and complete systems. Thanks to its highly flexible software-first architecture, ReOrbit can adapt its satellites to different missions and support any payloads with powerful flight capabilities whilst keeping cost and time-to-orbit low. ReOrbit has been profitable since it was founded, gaining strong traction with customers ranging from governmental and institutional sectors to commercial satellite operators.

“This is a very important milestone for ReOrbit, and we are thrilled to have secured this significant support from our new and existing investors,” says Sethu Saveda Suvanam, CEO and Founder of ReOrbit. “Our outstanding team is dedicated to delivering cutting-edge solutions that meet the highest global quality, security and operability standards. We can now accelerate our development strategy focusing on international expansion and products that make a difference. We have a very strong pipeline, and this funding will enable us to deliver multiple space systems”.

“ReOrbit represents the next frontier of the new space economy. We are happy to support the rapid growth of the company and its continuous impressive work on advancing breakthrough technologies in space.”, says Tuomas Kosonen, Partner at Inventure VC.

ReOrbit’s Board of Directors is led by the Chairman of the Board Nishant Batra, Chief Strategy and Technology Officer of Nokia, and includes esteemed members Tuomas Kosonen, Partner at Inventure VC, Markus Räikkönen, Investor at YES VC, Sethu Saveda Suvanam, CEO and Founder of ReOrbit, and John Auburn, Chief Strategy Officer of ReOrbit.

About ReOrbit

ReOrbit provides autonomous and interconnected satellites that are optimized for efficient and reliable delivery of customers space-related data. ReOrbit is creating the most compelling in-space data flow company by augmenting world’s information use via space.

ReOrbit works with the most prominent entities within security, satcom and Earth observation. Our technology is supported by Business Finland, the European Space Agency and the European Commission.

Founded in 2019, ReOrbit is headquartered in Helsinki, Finland with additional offices in Sweden and Argentina. For more information, please visit https://www.reorbit.space/

Contact
Media Contact:
Jana Avdeeva, Marketing Manager, ReOrbit
[email protected]
+358 504344104

SOURCE ReOrbit Oy


ThreatHunter.ai: This Labor Day Holiday in the Ruthless Digital Frontier, We Are Your First and Last Line of Defense

BREA, Calif., Sept. 1, 2023 — The Labor Day weekend may be a reprieve for many, but in the unforgiving digital battleground, there is no ceasefire. Cyber threats don’t take holidays, and neither do we. ThreatHunter.ai stands tall, a relentless sentinel in a world where a single breach can decimate reputations, finances, and futures.

Our Breach Hotline: 714-451-8803 isn’t a courtesy; it’s a necessity. It’s not just an emergency line; it’s a warline. Whether you’re an existing ally or find yourself blindsided by an unforeseen cyber assault, we’re your rapid response, ensuring immediate countermeasures.

James McMurry, CEO of ThreatHunter.ai, articulates it best: “Our team isn’t just dedicated; they’re battle-hardened. While the world seeks respite this Labor Day, our Threat Hunters are on the frontlines, eyes wide, senses sharper than ever, ready to strike back.”

At ThreatHunter.ai, we’re not just reactive; we’re predatory. We hunt threats before they hunt you. Our Expert Human Threat Hunters, armed with our ARGOS Platform, the best Intel and Counter-Intel from our 1MC Labs team, and the latest tools and an aggressive mindset, ensure that we’re not just another player; we’re the apex predator in the cybersecurity ecosystem.

The harsh lessons of the past, like previous holiday periods of catastrophic breaches at non customers, are not lost on anyone. They’re our fuel. ThreatHunter.ai operates with a sense of urgency, acknowledging that in the brutal cyber realm, even a second’s delay can be fatal.

But our ethos goes beyond just defense. We believe that when the digital hounds are at your door, everyone deserves a fighting chance.

Our Breach Hotline isn’t exclusive; it’s for every panicked call, every desperate plea, customers or not.

As you navigate the Labor Day celebrations, remember; in the ruthless digital wilderness, threats are always lurking.

But with ThreatHunter.ai by your side, they’re the ones who should be afraid.

If you are experiencing a breach, remember to call us 714.451.8803

Or email [email protected]

Semper Paratus.

About Threathunter.ai

ThreatHunter.ai, a 100% Service-Disabled Veteran Owned Small Business, is a leading provider of AI-driven threat hunting solutions. Its advanced machine learning algorithms and expert analysis help organizations detect, identify, and respond to cyber threats. Its solutions are designed to supplement existing security resources and provide a fresh perspective on how to address today’s complex cyber threats.

Don’t miss the opportunity to safeguard your organization with the unparalleled cybersecurity protection offered by ThreatHunter.ai.

Visit our website at www.threathunter.ai to explore our unique approach, learn more about our cutting-edge solutions, and discover how we can empower your business to stay ahead of cyber threats.

To speak with our experts or schedule a personalized demo, reach out to our sales team at [email protected] or call 714.515.4011.

Take action today and ensure the security and resilience of your digital infrastructure.

Media Contact:
Lydia Coulter
[email protected]
714-515-4011

SOURCE ThreatHunter.ai